Inactive Instrument

Highlights Torii Pharmaceutical Co., Ltd.

Equities

4551

JP3635800000

Pharmaceuticals

Highlights

02-27	Shionogi & Co., Ltd. and Torii Pharmaceutical Co., Ltd. Announce the Submission of an Application for Manufacturing and Marketing Approval for A 0.5% Lotion Formulation of the Atopic Dermatitis Treatment Corectim	CI
02-09	Verrica Pharmaceuticals Announces Launch of YCANTH for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical	CI
19/09/25	Torii Pharmaceutical Co. Ltd. Receives Approval for YCANTH (TO-208) in Japan for the Treatment of Molluscum Contagiosum	CI
31/08/25	Torii Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 7, 2025, has expired.	CI
10/07/25	Torii Pharmaceutical Co Ltd says it will retire treasury shares worth 2.39% of outstanding stock on Aug 29	RE
01/07/25	Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH for the Treatment of Common Warts	CI
19/06/25	Shionogi Completes Tender Offer for Torii Pharmaceutical, Acquiring 39% Stake	MT
17/06/25	Shionogi & Co., Ltd. completed the acquisition of 44.1% stake in Torii Pharmaceutical Co., Ltd. from group of sellers.	CI
07/05/25	Shionogi to Acquire Japan Tobacco's Pharma Business, Take Full Control of Torii Pharmaceutical	MT
07/05/25	Deals of the day-Mergers and acquisitions	RE
07/05/25	Torii Pharmaceutical Co., Ltd. announces an Equity Buyback for 15,398,800 shares, representing 54.78% for ¥70,341.72 million.	CI
07/05/25	Deals of the day-Mergers and acquisitions	RE
07/05/25	Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion	RE
07/05/25	Shionogi & Co: To Launch Tender Offer For Torii Pharmaceutical Shares At 6,350 Yen Per Share	RE
07/05/25	Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion	RE
07/05/25	Japan's Shionogi to buy Torii Pharmaceutical for $1 billion, Nikkei says	RE
07/05/25	Shionogi To Buy Torii Pharmaceutical For About 150 Billion Yen, Nikkei Says	RE
06/05/25	Torii Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	CI
06/05/25	Shionogi & Co., Ltd. proposed to acquire 44.1% stake in Torii Pharmaceutical Co., Ltd. from group of sellers for ¥80.7 billion.	CI
26/12/24	Final dividend	FA
06/12/24	Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan	CI
26/06/24	For interim dividend	FA
15/05/24	Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth	MT
15/05/24	Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts	CI
27/12/23	Final dividend	FA